The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Sign in to tag this notice and share notes on it with your team.
Winston AI writes a plain-English brief of every opportunity — what the buyer wants, and what affects whether to bid. It's free in every Scout workspace. Sign in to see it.
Supply of Compounded Aseptic Medicines to NHS Scotland.
| Lot | Title | Value |
|---|---|---|
| 1 | Compounded Aseptic MedicinesSupply of Compounded Aseptic Medicines to NHS Scotland. The Authority awards this Lot as a ranked multi-supplier framework. Molecules included within this Lot are as follows: CARBOPLATIN CETUXIMAB CYCLOPHOSPHAMIDE PEMBROLIZUMAB Full details of Goods and volumes can be found within the ITT documents. | — |
| 2 | Compounded Aseptic MedicinesSupply of Compounded Aseptic Medicines to NHS Scotland. The Authority awards this Lot as a ranked multi-supplier framework. Molecules included within this Lot are as follows: EPIRUBICIN FLUOROURACIL IRINOTECAN METHOTREXATE NIVOLUMAB RITUXIMAB Full details of Goods and volumes can be found within the ITT documents. | — |
| 3 | Compounded Aseptic MedicinesSupply of Compounded Aseptic Medicines to NHS Scotland. The Authority awards this Lot as a ranked multi-supplier framework. Molecules included within this Lot are as follows: BORTEZOMIB CISPLATIN DOCETAXEL DOXORUBICIN GEMCITABINE INFLIXIMAB OXALIPLATIN TRASTUZUMAB VINCRISTINE Full details of Goods and volumes can be found within the ITT documents. |
| Title | Supplier | Value | Awarded |
|---|---|---|---|
| Compounded Aseptic Medicines | ITH Pharma Limited | £40,584,100 | 1 Jul 2026 |
| Compounded Aseptic Medicines | ITH Pharma Limited | £23,420,770 | 1 Jul 2026 |
| Compounded Aseptic Medicines | Baxter Healthcare Ltd | £10,307,240 | 1 Jul 2026 |
| Compounded Aseptic Medicines | Baxter Healthcare Ltd | £8,354,897 | 1 Jul 2026 |
| — |
| 4 | Compounded Aseptic MedicinesSupply of Compounded Aseptic Medicines to NHS Scotland. The Authority awards this Lot as an un-ranked multi supplier framework to a maximum of three (3) Framework Participants per line. Molecules included within this Lot are as follows: BEVACIZUMAB CYTARABINE FLUOROURACIL PRE-FILLED PUMPS INSULIN METHOTREXATE NATALIZUMAB PACLITAXEL PANITUMUMAB TRASTUZUMAB VEDOLIZUMAB Full details of Goods and volumes can be found within the ITT documents. | — |